Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Yellow Card
Report side effects (MHRA)
Drug safety updates
MHRA alerts for Homeopathic arnica montana
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 14 · Randomised trials: 8 · 1992–2026
Showing the 50 most relevant studies, sorted by most relevant.
Wagenknecht A, Dörfler J, Freuding M, et al.
2023
- Breast Neoplasms
- Homeopathy
- Mastectomy
PurposeIn this systematic review we included clinical studies from 1800 until 2020 to evaluate evidence of the effectiveness of homeopathy on physical and mental conditions in patients during oncological treatment.MethodIn February 2021 a systematic search was conducted searching five electronic databases (Embase, Cochrane, PsychInfo, CINAHL and Medline) to find studies concerning use, effectiveness and potential harm of homeopathy in cancer patients.ResultsFrom all 1352 search results, 18 studies with 2016 patients were included in this SR. The patients treated with homeopathy were mainly diagnosed with breast cancer. The therapy concepts include single and combination homeopathic remedies (used systemically or as mouth rinses) of various dilutions. Outcomes assessed were the influence on toxicity of cancer treatment (mostly hot flashes and menopausal symptoms), time to drain removal in breast cancer patients after mastectomy, survival, quality of life, global health and subjective well-being, anxiety and depression as well as safety and tolerance. The included studies reported heterogeneous results: some studies described significant differences in quality of life or toxicity of cancer treatment favouring homeopathy, whereas others did not find an effect or reported significant differences to the disadvantage of homeopathy or side effects caused by homeopathy. The majority of the studies have a low methodological quality.ConclusionsFor homeopathy, there is neither a scientifically based hypothesis of its mode of action nor conclusive evidence from clinical studies in cancer care.
Abstract licence: CC BY
Loef M, van Haselen R, Baumgartner S
2026
- Materia Medica
- Homeopathy
- Research Design
BackgroundThe clinical benefits of homeopathic preparations (HPs) used in anthroposophic medicine and homeopathy remain a topic of debate. Systematic reviews (SRs), with or without meta-analyses (MAs), that assess the literature in line with scientific standards and account for the complex nature of these interventions are lacking for many health conditions. This project aims to conduct SRs to evaluate the efficacy, effectiveness, and safety of HPs for selected patient populations, using a pluralistic approach that considers internal and model validity.MethodsThis protocol follows PRISMA-P. A comprehensive literature search will include the HOMIS database, MEDLINE, EMBASE, CINAHL, Cochrane Central Register of Controlled Trials, AMED, LILACS, topic-specific sources, citation indices, trial registers, and grey literature, including preprint servers. Eligible studies will have a prospective, longitudinal design and include randomized controlled trials and non-randomized comparative studies published in various languages, evaluating HP interventions for efficacy, effectiveness, and/or safety in health conditions preselected through expert consensus. All patient types, interventions, co-interventions, therapeutic goals, and comparison groups will be eligible. Research questions and outcomes will be developed with consideration of the patient perspective. Each SR will be conducted by a multidisciplinary team, supported by an advisory group. Risk of bias will be assessed using ROB-2 and ROBINS-I. Model validity and the efficacy-effectiveness spectrum will be evaluated using MVHT and RITES. Intervention complexity will be analyzed with an adapted iCAT_SR. Where meta-analysis is not feasible, a narrative synthesis following SWiM will be conducted; otherwise, quantitative synthesis will be performed. Certainty of evidence will be assessed using GRADE.DiscussionThis series of SRs and MAs will investigate the effects of HPs as complex interventions in healthcare and aims to establish an evidence base regarding their efficacy, effectiveness, and safety. By integrating assessments of internal and model validity and potential effect modifiers, the reviews aim to provide a more comprehensive understanding of the conditions under which HPs may yield clinical benefits. In addition, the project may identify research gaps and methodological shortcomings to inform future studies.Systematic review registrationPROSPERO CRD420251017029.
Abstract licence: CC BY
Emily R Stack, Colby V Spongberg, Kathleen O'Neal, et al.
Cureus, 2026
Rebecca Knackstedt, James Gatherwright
Annals of Plastic Surgery, 2019
Tournier A, Klein SD, Würtenberger S, et al.
2019
- Materia Medica
- Homeopathy
- Bibliometrics
Objectives: In Part 1 of the review of physicochemical research performed on homeopathic preparations the authors identified relevant publications of sufficient reporting quality for further in-depth analysis. In this article, the authors analyze these publications to identify any empirical evidence for specific physicochemical properties of homeopathic preparations and to identify most promising experimental techniques for future studies. Methods: After an update of the literature search up to 2018, the authors analyzed all publications in terms of individual experiments. They extracted information regarding methodological criteria such as blinding, randomization, statistics, controls, sample preparation, and replications, as well as regarding experimental design and measurement methods applied. Scores were developed to identify experimental techniques with most reliable outcomes. Results: The publications analyzed described 203 experiments. Less than 25% used blinding and/or randomization, and about one third used adequate controls to identify specific effects of homeopathic preparations. The most promising techniques used so far are nuclear magnetic resonance (NMR) relaxation, optical spectroscopy, and electrical impedance measurements. In these three areas, several sets of replicated high-quality experiments provide evidence for specific physicochemical properties of homeopathic preparations. Conclusions: The authors uncovered a number of promising experimental techniques that warrant replication to assess the reported physicochemical properties of homeopathic preparations compared with controls. They further discuss a range of experimental aspects that highlight the many factors that need to be taken into consideration when performing basic research into homeopathic potentization. For future experiments, the authors generally recommend using succussed (vigorously shaken) controls, or comparing different homeopathic preparations with each other to reliably identify any specific physicochemical properties.
Abstract licence: CC BY
Allgemeine Homöopathische Zeitung, 2022
E. Ernst, M. Pittler
Archives of surgery, 1998
- Plants, Medicinal
- Phytotherapy
- Arnica
R. Lüdtke, Daniela Hacke
Wiener Medizinische Wochenschrift, 2005
- Arnica
- Phytotherapy
- Wounds and Injuries
A. Robertson, R. Suryanarayanan, A. Banerjee
Homeopathy, 2007
- Arnica
- Plant Extracts
- Pain Measurement
Stevinson C, Devaraj VS, Fountain-Barber A, et al.
2003
- Arnica
- Hand
- Carpal Tunnel Syndrome
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.